Humana Inc. (NYSE:HUM) is scheduled to announce its earnings results before the market opens on Wednesday, November 8th. Analysts expect the company to announce earnings of $3.25 per share for the quarter.
Humana Inc. (NYSE:HUM) opened at $256.69 on Monday. The company has a debt-to-equity ratio of 0.39, a current ratio of 1.65 and a quick ratio of 1.65. The firm has a market capitalization of $37,096.07, a price-to-earnings ratio of 22.30, a PEG ratio of 1.66 and a beta of 0.91. Humana Inc. has a 12 month low of $165.52 and a 12 month high of $264.56.
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, January 26th. Investors of record on Friday, December 29th will be paid a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a yield of 0.62%. The ex-dividend date of this dividend is Thursday, December 28th. Humana’s payout ratio is presently 13.06%.
Several analysts recently commented on the company. Credit Suisse Group reaffirmed an “outperform” rating and set a $260.00 price objective (up previously from $250.00) on shares of Humana in a research note on Thursday, August 3rd. Deutsche Bank AG raised their price objective on Humana from $234.00 to $243.00 and gave the stock a “hold” rating in a research note on Monday, August 7th. Oppenheimer Holdings, Inc. raised their price objective on Humana from $236.00 to $255.00 and gave the stock an “outperform” rating in a research note on Thursday, August 3rd. BidaskClub downgraded Humana from a “hold” rating to a “sell” rating in a research note on Thursday, August 17th. Finally, ValuEngine downgraded Humana from a “buy” rating to a “hold” rating in a research note on Tuesday, October 10th. Thirteen research analysts have rated the stock with a hold rating and eleven have issued a buy rating to the stock. The stock has an average rating of “Hold” and an average price target of $253.71.
COPYRIGHT VIOLATION NOTICE: This piece of content was originally posted by Community Financial News and is the sole property of of Community Financial News. If you are reading this piece of content on another domain, it was stolen and republished in violation of United States & international trademark & copyright law. The legal version of this piece of content can be read at https://www.com-unik.info/2017/11/06/humana-inc-hum-set-to-announce-quarterly-earnings-on-wednesday.html.
In related news, VP Timothy S. Huval sold 7,803 shares of Humana stock in a transaction dated Friday, September 1st. The stock was sold at an average price of $258.14, for a total transaction of $2,014,266.42. Following the completion of the transaction, the vice president now owns 8,831 shares in the company, valued at $2,279,634.34. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Elizabeth D. Bierbower sold 9,786 shares of Humana stock in a transaction dated Friday, September 1st. The stock was sold at an average price of $259.00, for a total value of $2,534,574.00. Following the transaction, the insider now owns 18,042 shares of the company’s stock, valued at approximately $4,672,878. The disclosure for this sale can be found here. Insiders have sold 55,595 shares of company stock valued at $14,133,706 in the last quarter. 0.80% of the stock is currently owned by corporate insiders.
Humana Company Profile
Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
What are top analysts saying about Humana Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Humana Inc. and related companies.